Moreover, down-regulation of PCAT-1 by interference RNA was enough to reduce cell proliferation in vitro, pointing to PCAT-1 as a potential therapeutic target of prostate cancer (Prensner et al., 2014). The gene discussed is PCAT1; the disease is prostate cancer.